Similar articles

• Profiles of four top biotech companies in India.

  Suresh N, Rao ChS. Suresh N, et al. Biotechnol J. 2009 Mar;4(3):295-300. doi: 10.1002/biot.200900028. Biotechnol J. 2009. PMID: 19296435 No abstract available.
• Downstream processing of value-added proteins in biotechnology: An Indian scenario.

  Babu AK, Vijayalakshmi MA. Babu AK, et al. Biotechnol J. 2009 Aug;4(8):1132-9. doi: 10.1002/biot.200900020. Biotechnol J. 2009. PMID: 19360713 Review. No abstract available.
• A new formula for finding drugs.

  Davies N, Peakman T, Arlington S. Davies N, et al. Drug Discov Today. 2004 Mar 1;9(5):197-9. doi: 10.1016/S1359-6446(03)02914-3. Drug Discov Today. 2004. PMID: 14980535 No abstract available.
• Private company profiles.

  [No authors listed] [No authors listed] Nat Biotechnol. 2003 Jul;21 Suppl:BE23-8. Nat Biotechnol. 2003. PMID: 12874973 No abstract available.
• The development of China's medical biotech industry needs to be driven by innovation.

  Yu Z, Dai Y. Yu Z, et al. Biotechnol J. 2006 Nov;1(11):1253-7. doi: 10.1002/biot.200600086. Biotechnol J. 2006. PMID: 17068752 Review.